223 related articles for article (PubMed ID: 22937007)
21. Bicyclic-Capped Histone Deacetylase 6 Inhibitors with Improved Activity in a Model of Axonal Charcot-Marie-Tooth Disease.
Shen S; Benoy V; Bergman JA; Kalin JH; Frojuello M; Vistoli G; Haeck W; Van Den Bosch L; Kozikowski AP
ACS Chem Neurosci; 2016 Feb; 7(2):240-58. PubMed ID: 26599234
[TBL] [Abstract][Full Text] [Related]
22. Amyloid beta-mediated KIF5A deficiency disrupts anterograde axonal mitochondrial movement.
Wang Q; Tian J; Chen H; Du H; Guo L
Neurobiol Dis; 2019 Jul; 127():410-418. PubMed ID: 30923004
[TBL] [Abstract][Full Text] [Related]
23. Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms.
Hiruma H; Katakura T; Takahashi S; Ichikawa T; Kawakami T
J Neurosci; 2003 Oct; 23(26):8967-77. PubMed ID: 14523099
[TBL] [Abstract][Full Text] [Related]
24. Structure-Based Discovery of A Small Molecule Inhibitor of Histone Deacetylase 6 (HDAC6) that Significantly Reduces Alzheimer's Disease Neuropathology.
Mondal P; Bai P; Gomm A; Bakiasi G; Lin CJ; Wang Y; Choi SH; Tanzi RE; Wang C; Zhang C
Adv Sci (Weinh); 2024 Jan; 11(1):e2304545. PubMed ID: 37990786
[TBL] [Abstract][Full Text] [Related]
25. Effect of β-amyloid (25-35) on mitochondrial function and expression of mitochondrial permeability transition pore proteins in rat hippocampal neurons.
Ren R; Zhang Y; Li B; Wu Y; Li B
J Cell Biochem; 2011 May; 112(5):1450-7. PubMed ID: 21321998
[TBL] [Abstract][Full Text] [Related]
26. Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS.
Taes I; Timmers M; Hersmus N; Bento-Abreu A; Van Den Bosch L; Van Damme P; Auwerx J; Robberecht W
Hum Mol Genet; 2013 May; 22(9):1783-90. PubMed ID: 23364049
[TBL] [Abstract][Full Text] [Related]
27. Cyclophilin D deficiency rescues axonal mitochondrial transport in Alzheimer's neurons.
Guo L; Du H; Yan S; Wu X; McKhann GM; Chen JX; Yan SS
PLoS One; 2013; 8(1):e54914. PubMed ID: 23382999
[TBL] [Abstract][Full Text] [Related]
28. Tau reduction prevents Abeta-induced defects in axonal transport.
Vossel KA; Zhang K; Brodbeck J; Daub AC; Sharma P; Finkbeiner S; Cui B; Mucke L
Science; 2010 Oct; 330(6001):198. PubMed ID: 20829454
[TBL] [Abstract][Full Text] [Related]
29. A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice.
Onishi T; Maeda R; Terada M; Sato S; Fujii T; Ito M; Hashikami K; Kawamoto T; Tanaka M
Sci Rep; 2021 Jul; 11(1):15423. PubMed ID: 34326423
[TBL] [Abstract][Full Text] [Related]
30. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease.
d'Ydewalle C; Krishnan J; Chiheb DM; Van Damme P; Irobi J; Kozikowski AP; Vanden Berghe P; Timmerman V; Robberecht W; Van Den Bosch L
Nat Med; 2011 Jul; 17(8):968-74. PubMed ID: 21785432
[TBL] [Abstract][Full Text] [Related]
31. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of AMPA receptor trafficking at hippocampal synapses by beta-amyloid oligomers: the mitochondrial contribution.
Rui Y; Gu J; Yu K; Hartzell HC; Zheng JQ
Mol Brain; 2010 Mar; 3():10. PubMed ID: 20346152
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic factors MeCP2 and HDAC6 control α-tubulin acetylation in cardiac fibroblast proliferation and fibrosis.
Tao H; Yang JJ; Shi KH; Li J
Inflamm Res; 2016 May; 65(5):415-26. PubMed ID: 26975406
[TBL] [Abstract][Full Text] [Related]
34. Tau--an inhibitor of deacetylase HDAC6 function.
Perez M; Santa-Maria I; Gomez de Barreda E; Zhu X; Cuadros R; Cabrero JR; Sanchez-Madrid F; Dawson HN; Vitek MP; Perry G; Smith MA; Avila J
J Neurochem; 2009 Jun; 109(6):1756-66. PubMed ID: 19457097
[TBL] [Abstract][Full Text] [Related]
35. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.
Calkins MJ; Manczak M; Mao P; Shirendeb U; Reddy PH
Hum Mol Genet; 2011 Dec; 20(23):4515-29. PubMed ID: 21873260
[TBL] [Abstract][Full Text] [Related]
36. Modulation of histone deacetylase 6 (HDAC6) nuclear import and tubulin deacetylase activity through acetylation.
Liu Y; Peng L; Seto E; Huang S; Qiu Y
J Biol Chem; 2012 Aug; 287(34):29168-74. PubMed ID: 22778253
[TBL] [Abstract][Full Text] [Related]
37. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
Noack M; Leyk J; Richter-Landsberg C
Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial dysfunction and calcium deregulation by the RanBP9-cofilin pathway.
Roh SE; Woo JA; Lakshmana MK; Uhlar C; Ankala V; Boggess T; Liu T; Hong YH; Mook-Jung I; Kim SJ; Kang DE
FASEB J; 2013 Dec; 27(12):4776-89. PubMed ID: 23982146
[TBL] [Abstract][Full Text] [Related]
39. Dexmedetomidine attenuates the toxicity of β‑amyloid on neurons and astrocytes by increasing BDNF production under the regulation of HDAC2 and HDAC5.
Wang Y; Jia A; Ma W
Mol Med Rep; 2019 Jan; 19(1):533-540. PubMed ID: 30483749
[TBL] [Abstract][Full Text] [Related]
40. HDAC6 deacetylates alpha tubulin in sperm and modulates sperm motility in Holtzman rat.
Parab S; Shetty O; Gaonkar R; Balasinor N; Khole V; Parte P
Cell Tissue Res; 2015 Feb; 359(2):665-678. PubMed ID: 25411052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
